loading
Schlusskurs vom Vortag:
$21.44
Offen:
$21.37
24-Stunden-Volumen:
596.12K
Relative Volume:
0.41
Marktkapitalisierung:
$2.60B
Einnahmen:
$460.48M
Nettoeinkommen (Verlust:
$142.80M
KGV:
17.98
EPS:
1.18
Netto-Cashflow:
$221.79M
1W Leistung:
-0.70%
1M Leistung:
+1.78%
6M Leistung:
-14.61%
1J Leistung:
-2.48%
1-Tages-Spanne:
Value
$21.06
$21.52
1-Wochen-Bereich:
Value
$20.72
$21.74
52-Wochen-Spanne:
Value
$19.05
$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Name
Firmenname
Catalyst Pharmaceuticals Inc
Name
Telefon
(305) 529-2522
Name
Adresse
355 ALHAMBRA CIRCLE, CORAL GABLES
Name
Mitarbeiter
167
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
CPRX's Discussions on Twitter

Vergleichen Sie CPRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CPRX
Catalyst Pharmaceuticals Inc
21.21 2.62B 460.48M 142.80M 221.79M 1.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.67 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
631.49 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
425.97 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
838.79 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
184.66 39.72B 447.02M -1.18B -868.57M -6.1812

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-04 Eingeleitet Robert W. Baird Outperform
2024-11-18 Eingeleitet Stephens Overweight
2024-03-14 Eingeleitet Citigroup Buy
2024-03-07 Eingeleitet BofA Securities Buy
2023-12-21 Eingeleitet Oppenheimer Outperform
2022-08-24 Herabstufung ROTH Capital Buy → Neutral
2018-09-21 Eingeleitet Cantor Fitzgerald Overweight
2018-09-07 Fortgesetzt Piper Jaffray Overweight
2016-10-05 Hochstufung Piper Jaffray Neutral → Overweight
2016-04-26 Herabstufung Piper Jaffray Overweight → Neutral
2014-09-30 Bestätigt ROTH Capital Buy
2014-09-16 Bestätigt ROTH Capital Buy
2014-09-15 Bestätigt H.C. Wainwright Buy
2013-10-21 Bestätigt Aegis Capital Buy
2013-09-24 Eingeleitet Maxim Group Buy
2013-09-06 Bestätigt Aegis Capital Buy
2013-04-18 Eingeleitet Aegis Capital Buy
2012-08-27 Hochstufung Rodman & Renshaw Mkt Perform → Mkt Outperform
2009-10-01 Hochstufung Merriman Sell → Neutral
2009-05-29 Herabstufung Hapoalim Neutral → Underperform
2009-05-29 Herabstufung Merriman Curhan Ford Buy → Sell
2008-12-15 Eingeleitet Merriman Curhan Ford Buy
2007-11-28 Eingeleitet Rodman & Renshaw Mkt Outperform
2007-01-31 Eingeleitet Stifel Nicolaus Buy
2007-01-05 Eingeleitet First Albany Buy
Alle ansehen

Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten

pulisher
07:52 AM

Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Prev - GuruFocus

07:52 AM
pulisher
07:46 AM

Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

07:46 AM
pulisher
06:41 AM

Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com

06:41 AM
pulisher
06:30 AM

Hussman Strategic Advisors Inc. Purchases 63,000 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

06:30 AM
pulisher
06:29 AM

What risks investors should watch in Catalyst Pharmaceuticals Inc. stockPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com

06:29 AM
pulisher
05:32 AM

Momentum divergence signals in Catalyst Pharmaceuticals Inc. chartEarnings Growth Report & Technical Pattern Recognition Alerts - newser.com

05:32 AM
pulisher
03:36 AM

Relative strength of Catalyst Pharmaceuticals Inc. in sector analysis2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com

03:36 AM
pulisher
02:12 AM

Will Catalyst Pharmaceuticals Inc. stock split again soonJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com

02:12 AM
pulisher
01:31 AM

Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden - GlobeNewswire Inc.

01:31 AM
pulisher
01:15 AM

Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com

01:15 AM
pulisher
Nov 03, 2025

Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Historical Comparison & Risk Controlled Daily Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why global investors buy Catalyst Pharmaceuticals Inc. (CN2) stockWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weakness2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Quarterly Portfolio Report & Expert Curated Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

Can Catalyst Pharmaceuticals Inc. hit a new high this monthEarnings Overview Report & High Return Stock Watch Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What analyst consensus says on Catalyst Pharmaceuticals Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat

Nov 03, 2025
pulisher
Nov 02, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Catalyst Pharmaceuticals Inc. recovery potential after sell offWeekly Trade Report & Entry Point Confirmation Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Moody Aldrich Partners LLC - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

Will Catalyst Pharmaceuticals Inc. (CN2) stock sustain uptrend momentumBuy Signal & Community Verified Watchlist Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Catalyst Pharmaceuticals Inc. stock bottoming outWeekly Stock Recap & Low Risk Entry Point Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsAnalyst Downgrade & Stock Portfolio Risk Control - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How rising interest rates impact Catalyst Pharmaceuticals Inc. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com

Oct 31, 2025

Finanzdaten der Catalyst Pharmaceuticals Inc-Aktie (CPRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.74
price up icon 1.11%
$28.97
price up icon 0.87%
$101.64
price up icon 0.11%
$104.00
price up icon 0.11%
biotechnology ONC
$311.73
price down icon 0.04%
$184.66
price down icon 0.80%
Kapitalisierung:     |  Volumen (24h):